BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11365963)

  • 1. New TB guidelines for persons with HIV.
    AIDS Treat News; 1998 Nov; (No 306):6. PubMed ID: 11365963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Mar; 49(9):185-9. PubMed ID: 11795500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Mar; 51(10):214-5. PubMed ID: 11922192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A short two-drug regimen prevents active TB.
    Torres G
    GMHC Treat Issues; 1998 Apr; 12(4):12. PubMed ID: 11365399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention.
    MMWR Recomm Rep; 1998 Oct; 47(RR-20):1-58. PubMed ID: 9809743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TB drugs interact adversely with protease inhibitors.
    AIDS Alert; 1996 Oct; 11(10):117-8. PubMed ID: 11363854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating concurrent HIV and TB. Centers for Disease Control and Prevention.
    AIDS Clin Care; 1996 Dec; 8(12):97-100, 104. PubMed ID: 11363993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues in the treatment of active tuberculosis in human immunodeficiency virus-infected patients.
    Schluger NW
    Clin Infect Dis; 1999 Jan; 28(1):130-5. PubMed ID: 10028083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical update: impact of HIV protease inhibitors on the treatment of HIV-infected tuberculosis patients with rifampin.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Oct; 45(42):921-5. PubMed ID: 8927017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of tuberculosis in people living with HIV.
    Granich R; Akolo C; Gunneberg C; Getahun H; Williams P; Williams B
    Clin Infect Dis; 2010 May; 50 Suppl 3():S215-22. PubMed ID: 20397951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management strategies for candidates for protease inhibitors and requiring treatment for Mycobacterium tuberculosis. TB/HIV Advisory Committee.
    Can Commun Dis Rep; 1998 May; 24(10):77-80. PubMed ID: 9613030
    [No Abstract]   [Full Text] [Related]  

  • 12. Tuberculosis: guidelines changed for latent TB treatment.
    AIDS Treat News; 2001 Sep; (371):3. PubMed ID: 11668976
    [No Abstract]   [Full Text] [Related]  

  • 13. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Government guidelines issued for TB control in correctional facilities.
    Mendelson D
    Nev Rnformation; 1996 May; 5(2):19. PubMed ID: 8826322
    [No Abstract]   [Full Text] [Related]  

  • 15. Tuberculosis therapy and the new protease inhibitors.
    Torres G
    GMHC Treat Issues; 1996 Nov; 10(11):11-2. PubMed ID: 11364009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New TB therapy works for HIV-positive patients.
    AIDS Alert; 1998 May; 13(5):58-9. PubMed ID: 11365414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review editorial: prevention of tuberculosis in resource-poor countries with increasing access to highly active antiretroviral treatment.
    Apers L; Lynen L; Worodria W; Colebunders R
    Trop Med Int Health; 2005 Dec; 10(12):1209-14. PubMed ID: 16359399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.
    McIlleron H; Meintjes G; Burman WJ; Maartens G
    J Infect Dis; 2007 Aug; 196 Suppl 1():S63-75. PubMed ID: 17624828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on treatment and prevention guidelines for HIV-related tuberculosis.
    Chaisson RE
    Hopkins HIV Rep; 1999 May; 11(3):3,10,12. PubMed ID: 11367371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculosis management for people with HIV infection.
    AIDS Inst Newsl; 1995 Jun; ():1-8. PubMed ID: 11367416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.